ADAMTS13 and androgen insensitivity syndrome: We found that serum ADAMTS13 levels at 72 h after IVT were significantly lower in AIS patients with poor outcomes compared with those with a good prognosis 551,181.00(IQR 440,539.00 to 788,283.50) pg/ml vs. 769,107.00(IQR 565,397.50 to 1,366,444.50) pg/ml, P = 0.021).